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Research
AbstrACt
Objective To provide a comprehensive review of the 
impact on intention to change health-related behaviours 
and health-related behaviours themselves, including 
screening uptake, of interventions incorporating 
information about cancer risk targeted at the general adult 
population.
Design A systematic review and random-effects meta-
analysis.
Data sources An electronic search of MEDLINE, EMBASE, 
CINAHL and PsycINFO from 1 January 2000 to 1 July 
2017.
Inclusion criteria Randomised controlled trials of 
interventions including provision of a personal estimate 
of future cancer risk based on two or more non-genetic 
variables to adults recruited from the general population 
that include at least one behavioural outcome.
results We included 19 studies reporting 12 outcomes. 
There was significant heterogeneity in interventions 
and outcomes between studies. There is evidence that 
interventions incorporating personalised cancer risk 
information do not affect intention to attend or attendance 
at screening (relative risk 1.00 (0.97–1.03)). There is 
limited evidence that they increase smoking abstinence, 
sun protection, adult skin self-examination and breast 
examination, and decrease intention to tan. However, 
they do not increase smoking cessation, parental child 
skin examination or intention to protect skin. No studies 
assessed changes in diet, alcohol consumption or physical 
activity.
Conclusions Interventions incorporating personalised 
cancer risk information do not affect uptake of screening, 
but there is limited evidence of effect on some health-
related behaviours. Further research, ideally including 
objective measures of behaviour, is needed before cancer 
risk information is incorporated into routine practice for 
health promotion in the general population.
IntrODuCtIOn 
In 2006, the US National Cancer Institute 
recognised risk-prediction models as an ‘area 
of extraordinary opportunity’.1 Since then, 
an increasing number of risk-prediction 
models have been developed. Such models 
can facilitate a personalised approach to 
cancer prevention and treatment and a more 
equitable and cost-effective distribution of 
finite resources by targeting screening and 
prevention activities at those most likely to 
benefit. Furthermore, being able to esti-
mate, communicate and monitor individual 
risk and demonstrate the impact of lifestyle 
change on future risk of cancer may comple-
ment wider collective approaches to shifting 
population distributions of behaviour, risk 
factors and cancer risk.
Research has shown that many individuals 
have incorrect perceptions of their risk of 
cancer2–4 and that both overestimation and 
underestimation are associated with maladap-
tive health-related behaviours.5 Additionally, 
while up to 40% of all cancers are attributable 
strengths and limitations of this study
 ► This systematic review is the first comprehensive 
review of the effect on intention and health-related 
behaviour of individuals in the general population 
of interventions delivered across multiple settings 
which incorporate personalised information about 
cancer risk.
 ► The use of a broad search strategy across multiple 
databases enabled us to identify 19 randomised 
controlled trials reporting the impact of interventions 
incorporating personalised cancer risk information 
on 12 outcomes.
 ► However, there was large heterogeneity across the 
studies, including the content of interventions and 
the outcome measures. This meant that it was only 
possible to meta-analyse one outcome, attendance 
at screening and, in many studies, separating the 
effect of the risk information alone from additional 
elements of the interventions was not possible.
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to lifestyle factors,6 only 3% of people are aware that being 
overweight can increase their risk of cancer and less than 
a third that physical activity could help reduce risk.7–10 
One in seven people additionally believes that lifetime 
risk of cancer is unmodifiable.11 Most behaviour change 
theories suggest that perceived risk is important along-
side other constructs such as self-efficacy and response 
efficacy in promoting behaviour change.12 13 Providing 
individuals with estimates of their risk of cancer alongside 
other behaviour change interventions may therefore help 
motivate behaviour change at an individual level. It may 
also enable individuals to make more informed decisions 
about uptake of screening tests for cancer. This has led 
to the development of an increasing number of interven-
tions incorporating information about cancer risk being 
developed.
Understanding the impact of interventions incorpo-
rating information about cancer risk on behaviour and 
intention to change behaviour before they are intro-
duced into routine practice is important. Previous system-
atic reviews in this area have focused only on trials in 
primary care14 or tailored information about cancer risk 
and screening.15 16 In this review, we aimed to provide a 
comprehensive synthesis of the impact of interventions 
incorporating personalised information about cancer 
risk on intention to change health-related behaviours 
and health-related behaviours within the general adult 
population.
MethODs
We performed a systematic literature review following an 
a priori established study protocol (available on request). 
Reporting followed the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses statement.17
search strategy
We performed an electronic literature search of 
MEDLINE, EMBASE, CINAHL and PsycINFO from 
January 2000 to July 2017 with no language limits using 
a combination of subject headings and free text incor-
porating ‘cancer’, ‘risk/risk factor/risk assessment’ and 
‘prediction/model/score/tool’ (see online supplemen-
tary file 1 for the complete search strategies). We then 
extended the search by manually screening the refer-
ence lists of all included papers. We chose to begin the 
search in 2000 as the previous review of tailored infor-
mation about cancer risk and screening had noted that 
computer-delivered interventions, as would be required 
for calculating risk scores, were only described in publica-
tions from 2000 onwards.15
study selection
We included studies if they were randomised controlled 
trials (RCTs) published as a primary research paper in a 
peer-reviewed journal, included adults with no previous 
history of cancer, included provision to individuals of a 
personal estimate of future cancer risk based on two or 
more non-genetic variables, and reported at least one 
behavioural outcome. In order to focus on the provision 
of personalised cancer risk to the general population, we 
excluded studies which had recruited participants on the 
basis of a personal or family history of cancer or following 
referral to specialist cancer risk services. Vignette, before-
and-after studies without a control group, cross-sectional, 
longitudinal and qualitative studies were also excluded 
along with conference abstracts, editorials, commentaries 
and letters.
Two reviewers (JAU-S and BS) each screened half of the 
titles and abstracts to exclude papers that were clearly not 
relevant. A third reviewer (SJG) independently assessed 
a random selection of 5% of the papers screened by 
each of the first reviewers. The full text was examined if 
a definite decision to exclude could not be made based 
on title and abstract alone. Two reviewers (JAU-S and BS) 
independently assessed all full-text papers. We discussed 
papers for which it was unclear whether or not the inclu-
sion criteria were met at consensus meetings with a third 
reviewer (SJG). Papers written in languages other than 
English were translated into English for assessment and 
subsequent data extraction.
Data extraction
Two researchers (JAU-S+BS/KM) independently 
extracted data from studies included in the review using 
a standardised data abstraction form to reduce bias. The 
data extracted included: (1) study characteristics (cancer 
type, study design, study setting or duration of follow-up), 
(2) selection of participants (inclusion criteria or method 
of recruitment/randomisation), (3) participant char-
acteristics (age, level of cancer risk or sample size), (4) 
intervention (risk tool used, method and format of risk 
communication, additional information or follow-up 
provided) and (5) measured outcome(s). Reviewers were 
not blinded to publication details.
Quality assessment
We conducted quality assessment at the same time as 
data extraction using a checklist based on the Critical 
Appraisal Skills Programme guidelines18 as an initial 
framework. This includes eight questions concerning 
whether the study addressed a clearly focused issue, the 
method of recruitment and randomisation, whether 
blinding was used, the measurement of the exposure and 
outcome, the comparability of the study groups and the 
follow-up. Each study was then classified as high, medium 
or low quality. No studies were excluded based on quality 
alone.
Data synthesis and statistical analysis
For analysis, we grouped the measured outcomes into 
those relating to: (1) preferences or intention to attend 
cancer screening, (2) cancer screening uptake, (3) inten-
tion or motivation to change health-related behaviour 
and (4) change in health-related behaviour. It was only 
possible to pool results for screening attendance. For this, 
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we used random-effects meta-analysis19 and the ‘metan’ 
package in STATA. We present intervention effects as rela-
tive risk (RR) rather than OR to avoid overestimating the 
risk.20 We estimated the heterogeneity between studies 
using the I2 statistic. All analyses were conducted using 
statistical software package STATA/SE V.12.
results
After duplicates were removed, the search identified 
38 906 papers. Of these, 35 604 were excluded at title and 
abstract level and a further 183 after full-text assessment. 
After title and abstract screening by the first reviewers 
(JAU-S and BS), no additional papers met the inclu-
sion criteria in the random 5% screened by the second 
reviewer (SJG). The most common reasons for exclusion 
at full-text level were that the papers did not include 
provision of a personal risk estimate (n=62), did not 
include any data on predefined outcomes (n=37), were 
conference abstracts (n=20) or were not primary research 
(n=16) (figure 1). Five further papers were identified 
through citation searching, giving 19 studies included in 
the analysis.
A summary of the participants and setting of those 19 
studies is shown in table 1. With the exception of three 
studies conducted in the UK,21–23 all studies took place 
in the USA. Most recruited participants from those 
attending primary care clinics (n=3) or lists of poten-
tially eligible individuals from electronic medical records 
(n=7), telephone services (n=1), insurance records 
(n=1) or survey companies (n=1). Two recruited through 
schools, community centres and universities, one from 
those calling a cancer information service and three used 
public advertisements.
In eight studies personalised information was provided 
about risk of breast cancer, in five about risk of colorectal 
cancer (CRC), in three risk of skin cancer, one lung 
cancer, one cervical cancer and one multiple cancers. 
Further details of the risk models used to calculate the 
risk estimate provided to participants and the format of 
the intervention(s) are given in table 2. All eight studies 
providing personalised information about breast cancer 
risk used the Gail risk model.24 This was the first risk 
model developed for breast cancer and includes age, age 
at menarche, age at first live birth, number of previous 
biopsies, number of biopsies showing atypical hyper-
plasia and number of first-degree relatives with breast 
cancer. Where details were given (n=3), all studies on 
CRC used the Harvard Cancer Risk tool25 which includes 
family history, height and weight, alcohol consumption, 
vegetable and red meat consumption, physical activity, 
screening history, a history of inflammatory bowel 
disease and use of aspirin, folate and female hormones. 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow diagram. RCT, randomised controlled 
trial. 
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Other risk models used were the Liverpool Lung Project 
model,26 Family Healthware tool,27 Wilkinson score for 
cervical cancer28 and the Brief Skin Cancer Risk Assess-
ment Tool29 adapted for children. Quality assessment for 
each of the study is provided in online supplementary file 
2. Seven were assessed as high or medium/high quality, 
11 as medium quality and one as medium/low.
Overall findings and evidence synthesis along with the 
number and quality of studies addressing each outcome 
are summarised in table 3.
Preferences and intentions for screening
Preferences for screening
Two RCTs reported participants’ views about screening. 
In the cluster-randomised trial by Holloway et al,21 partici-
pants who received a 10 min counselling session including 
information about relative and absolute risks of cervical 
cancer integrated within a smear test appointment were 
significantly less likely to state a preference for the next 
interval for cervical screening to be 12 months or less 
than those who received usual care (OR 0.51 (95% CI 
0.41 to 0.64)). The second study by Lipkus and Klein30 
reported attitudinal ambivalence towards faecal occult 
blood test (FOBT) screening measured by their agree-
ment with three Likert-style items stating that they had 
‘mixed feelings’, felt ‘torn’ and had ‘conflicting thoughts’ 
about whether to get screened for CRC using an FOBT. 
Participants who received personalised estimates of either 
absolute or absolute plus comparative risk alongside 
written information about CRC screening had signifi-
cantly lower ambivalence than those who received the 
same written information without tailored CRC risk infor-
mation (P<0.05).
Intention to attend cancer screening
Eight studies assessed intentions to attend cancer screening: 
five for mammography and three for CRC screening. Five 
showed no effect of risk information, three in which the only 
substantial difference between the intervention and control 
groups was the provision of a risk estimate.31–33 Bodurtha et 
al31 found no significant differences at 18 months between 
those randomised to receive either printed sheets with their 
5-year and lifetime estimates of breast cancer risk alongside 
information addressing barriers to mammography, breast 
cancer seriousness and benefits of yearly mammography or 
general information about breast cancer prevention prac-
tices not tailored to their risk level (OR after adjusting for 
baseline intentions and recruitment site 0.97 (95% CI 0.70 
to 1.33)). Davis et al34 reported that women who received 
a brief intervention over the telephone including informa-
tion about lifetime risk of cancer and screening recommen-
dations were no more likely at 1 month to report being in 
the maintenance stage (having had one mammogram in 
the past 2 years and two or more in the past 4 years and plan-
ning to get another on schedule) than the control group 
who received no intervention (67% in the intervention 
group compared with 68% in the control group). Helmes 
et al35 reported changes in a single breast health intentions A
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measure which included intention to have mammography, 
clinical breast examination and breast self-examination. 
They found no significant differences at baseline (P=0.23) or 
3-month follow-up (P=0.46) between women who received 
estimates of their lifetime risk of breast cancer along with 
information about breast awareness either face-to-face 
or over the telephone and a control group who received 
no intervention. Schroy et al36 randomised participants to 
complete an interactive 20–30 min computer-based deci-
sion aid which either did or did not include a personalised 
risk assessment. There was no difference between groups 
on a five-point scale of how sure they were that they would 
schedule a CRC screening test (mean scores 4.3 (SD 1.0) 
for both groups). Trevena et al33 similarly reported no effect 
on intention to have CRC screening of a 20-page decision 
aid including information about baseline risk and absolute 
reduction in CRC mortality with screening, compared with 
a three-page booklet with information and recommenda-
tions about screening.
The two studies reporting an effect were by Lipkus 
and Klein30 and Seitz et al.37 In Lipkus and Klein, inten-
tion to complete an FOBT that would be given to them 
within the following month was measured on a seven-
point Likert scale. The intentions reported by partici-
pants who received absolute risk (mean 3.65, n=40) or 
absolute plus either low (mean 6.43, n=38) or high (mean 
Table 3 Summary of evidence on outcomes
Outcome measure
No of 
studies
Studies with significant 
positive effect Studies with no effect
Best evidence 
synthesis
Screening
Preferences for screening 2 One medium-quality/
high-quality and one 
high-quality RCT
None Evidence of positive 
effect
Intention to attend screening 8 One medium-quality 
RCT*
One high-quality, one 
medium-quality/high-
quality and four medium-
quality RCTs*
Evidence of no effect
Attendance at screening 12 One high-quality RCT Two high-quality, 
two medium-quality/
high-quality and seven 
medium-quality studies
Evidence of no effect
Health-related behaviours
Intention to change health-related behaviours
  To tan 1 One low/medium RCT None Limited evidence of 
positive effect
  To protect skin 1 None One low/medium RCT Limited evidence of no 
effect
Health-related behaviours
  Smoking cessation 1 None One high-quality RCT Limited evidence of no 
effect
  Smoking abstinence 1 One high-quality RCT None Limited evidence of 
positive effect
  Sun protection 2 Two medium-quality 
RCTs
Indicative evidence of 
positive effect
  Tanning bed usage 1 None One low/medium RCT Limited evidence
  Adult skin examination 2 Two medium-quality 
RCTs
None Indicative evidence of 
positive effect
  Child skin examination 1 None One medium-quality RCT Limited evidence of no 
effect
  Breast examination 3 Two high-quality RCTs One medium/high RCT Indicative evidence of 
positive effect
  Diet 0 None None No evidence
  Physical activity 0 None None No evidence
  Alcohol 0 None None No evidence
*One medium-quality study reported a significant positive effect in low-risk women and no effect in high-risk women.
RCT, randomised controlled trial.
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6.65, n=39) comparative risk information were statisti-
cally significantly higher (P<0.05) than those participants 
in the control group who were provided with the same 
written information but without risk estimates (mean 
2.21, n=43). The mean intention reported by the group 
which received the comparative risk was also significantly 
higher than for the absolute risk only group. In Seitz et 
al, women were separated into those with an estimated 
10-year breast cancer risk above or below 1.5%. Intention 
to wait until age 50 before undergoing a mammogram 
was measured for those with a risk <1.5% and intention to 
start or continue to undergo mammograms in their 40s 
for those with a risk ≥1.5. In the low-risk group, all risk-
based intervention conditions resulted in a significant 
increase in the percentage of women planning to wait to 
age 50. However, in the high-risk group, no such signifi-
cant difference was seen.
The eighth study by Lipkus et al38 reported the differ-
ence in intentions to get a mammogram between one 
group that received a one-page handout including their 
estimated absolute risk and another group that received 
the same handout plus information concerning how their 
risk compared with a woman of their age and race at the 
lowest level of risk. Immediately after the provision of risk 
information, overall 2.5%, 67.8% and 24.8% reported that 
the risk information lowered, did not affect or increased 
their intentions to undergo a mammogram, respectively, 
with no differences between the groups.
Attendance at screening
Twelve RCTs reported attendance at screening: six for 
mammography31 34 39–42, five for CRC30 32 33 39 43 and one 
for cervical cancer.21 Except for one high-quality RCT in 
which the intervention group received information sheets 
including general information on breast cancer risk along-
side personalised risk information and telephone coun-
selling and the offer for more intensive group or genetic 
counselling,42 all showed no effect of the risk-based inter-
ventions as shown in the meta-analysis (figure 2) with a 
combined RR of 1.02 (95% CI 0.98 to 1.03, I2 61.6%).
Intention to change health-related behaviours
Intention to tan or protect skin
One RCT by Greene and Brinn measured intention 
to tan on a six-item Likert-type scale and intention to 
protect skin using a three-item scale.44 Participants who 
completed a self-assessment risk score alongside receiving 
generic information about tanning, tanning beds and sun 
exposure reported significantly decreased intentions to 
use tanning beds than those receiving the same generic 
information alone (2.68, n=70 compared with 3.19, n=71, 
P<0.05). In contrast, there were no significant differences 
in intentions to protect skin (2.38, n=70 compared with 
2.49, n=71, P>0.05).
Change in health-related behaviours
Smoking status
One high-quality RCT23 reported the impact of risk infor-
mation on smoking status. Receiving a personalised risk 
estimate in addition to a generic leaflet did not predict 
self-reported smoking status at 6 months in current 
smokers (P=0.66) but was associated with an increased 
odds of remaining a former smoker in those who had 
recently quit (OR 1.91 (95% CI 1.03 to 3.55)).
Figure 2 Relative risk for adherence to recommended screening postintervention. AR, absolute risk; CR, comparative risk; 
CRC, colorectal cancer; FOBT, faecal occult blood test. 
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Sun exposure and sun protection habits
Two RCTs22 45 measured sun protection habits by survey 
completion at baseline and follow-up. One by Glanz et 
al compared the effect on childhood sun exposure and 
sun protection habits of three mailings with person-
alised risk feedback, interactive skin cancer education 
materials and a family fun guide to a single mailing of 
standardised skin cancer information.45 The other by 
Glazebrook et al compared usual care with a self-directed 
computer program including individualised feedback of 
risk alongside sections on skin protection, how to detect 
melanoma, dangers of sun exposure, how to check skin 
and how to reduce risk.22 Both showed increases in 
overall sun protection habits (increase in sun protection 
habits index 0.19 in the intervention group compared 
with 0.14, P=0.02)45 and mean difference in skin protec-
tive behaviour score between intervention and control 
at 6-month follow-up 0.33 (95% CI 0.09 to 0.57)22 with 
variable results for individual aspects including wearing 
a sun hat, wearing a shirt, wearing sunglasses, use of sun 
cream, number of sunburns, staying in the shade and sun 
exposure during weekdays and weekends.
Tanning bed usage
The RCT by Greene and Brinn44 measured change in 
tanning behaviour and tanning bed usage. Participants 
who completed the self-assessment risk score reported 
lower rates of tanning bed usage in the previous month at 
follow-up (2.18, n=70 compared with 3.76, n=71, P<0.05) 
but no difference in change in tanning behaviour 
from preintervention to postintervention (−1.25, 
n=70 compared with −2.08, n=71, P>0.05).
Self/parent skin examination
The two RCTs by Glanz et al and Glazebrook et al,22 
measured rates of skin examination in adults or parents 
and children.45 Both showed statistically significant 
increases among adults and parents receiving person-
alised risk information (P<0.05), whereas the increase 
in parents examining their children was not statistically 
significant (P=0.06).
Clinical breast examination and breast self-examination
Three RCTs31 41 42 measured rates of clinical breast 
examination and/or breast self-examination following 
provision of risk information. In the RCT by Bodurtha 
et al, no significant differences were seen between those 
randomised to receive printed sheets including estimates 
of 5-year and lifetime risk of breast cancer alongside 
information addressing barriers to mammography, breast 
cancer seriousness and benefits of yearly mammography 
and those receiving general information about breast 
cancer prevention practices not tailored to their risk level 
for either frequency of clinical breast examination (crude 
rates: 91.4% vs 91.0%; adjusted OR 1.00 (95% CI 0.60 to 
1.66)) or breast self-examination (crude rates: 56.8% vs 
57.6%; adjusted OR 0.95 (95% CI 0.67 to 1.33)).31 The 
other two studies, both by Bowen et al, found significantly 
(P<0.01) greater increases in the proportion reporting 
performing breast self-examination in the intervention 
groups (35% to 52% and 36% to 62%) compared with 
controls (33% to 36% and 38% to 40%).41 42 However, 
both these studies compared intensive interventions 
(four weekly 2-hour sessions led by a health counsellor41 
or information sheets plus telephone counselling and the 
offer of more intensive group or genetic counselling42) 
with delayed intervention.
DIsCussIOn
This systematic review is, to our knowledge, the first review 
of the impact of interventions delivered across multiple 
settings which incorporate personalised information 
about cancer risk on intention to change health-related 
behaviour and health-related behaviours themselves in 
the general population. The findings show that such 
interventions do not affect intention to attend or atten-
dance at screening. There is limited evidence that they 
increase smoking abstinence, sun protection, adult skin 
self-examination and breast examination and decrease 
intention to tan. However, this was not seen for smoking 
cessation, parental child skin examination or intention 
to protect skin. There is a notable absence of studies 
assessing the impact on diet, physical activity and alcohol 
consumption with only one reporting smoking status and 
none including objective measures of behaviour.
Our finding that interventions incorporating person-
alised information about cancer risk had no effect on 
intention to attend or attendance at screening is consis-
tent with a previous Cochrane review in which person-
alised risk communication had little effect on the uptake 
of screening tests (fixed-effect OR 0.95 (95% CI 0.78 to 
1.15)).16 However, as in that review, there was evidence 
of increased concordance between screening preferences 
and recommendations and decreased ambivalence. This 
supports the suggestion made in that review that person-
alised risk information might be useful for shared and 
informed decision-making. For example, in surveys of 
participants about their knowledge and values for cancer 
screening decisions and decision-making processes, only 
21% report feeling extremely well informed,46 and the 
majority overestimate lifetime risk of cancer incidence 
and mortality.46 47 While providing individuals with infor-
mation about their estimated cancer risk may therefore 
not influence overall rates of screening, it may contribute 
to the decision to take up screening or not at an indi-
vidual level and support shared decision-making.
The absence of significant effects on health-related 
behaviours is also consistent with research in other disease 
areas, such as cardiovascular disease, where systematic 
reviews have found only few studies reporting behaviour 
change and no significant effects on lifestyle.48–50 This 
is perhaps not surprising given that behaviour change 
is influenced by many other factors, including health 
beliefs, social context, the environment and personal 
attributes such as time orientation.12 13 However, there was 
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no evidence that interventions that include information 
about cancer risk result in harm through false reassur-
ance and the adoption of unhealthy behaviours. This is 
important as on average many of the general population 
overestimate their own risk of cancer,30 35 41 51–53 and so 
if information about cancer risk were routinely provided 
within clinical practice, large numbers would be receiving 
an estimate lower than their prior perceptions.
The main strengths of this review are the systematic 
search of multiple electronic databases and the broad inclu-
sion criteria. This allowed us to include studies that assess 
the impact of interventions incorporating personalised 
cancer risk information on multiple behavioural outcomes. 
However, from nearly 40 000 titles and abstracts, we only 
included 14 with an additional five found through cita-
tion searching. This highlights the challenge in identifying 
studies in this area in which the primary purpose may not 
be related to the provision of personalised risk information. 
There was also significant heterogeneity in the outcome 
measures included, duration of follow-up and method of 
recruitment across the included studies. For all outcomes, 
except attendance at screening, there were either too few 
studies to meaningfully pool results or each study used 
different non-comparable measures. Even for attendance 
at screening for which meta-analysis was possible, we were 
only able to pool crude estimates, and the included studies 
addressed screening for breast, bowel and cervical cancer. 
While it is possible that the impact on screening attendance 
might be different across the different cancer sites because 
of the nature of the tests involved, the finding that only 
one study of mammography showed an effect of interven-
tions incorporating personalised cancer risk information 
suggests that this is unlikely to be the case. The duration 
of follow-up also varied from 1 to 18 months. However, the 
studies with shorter follow-up were those with intention 
as the outcome measures and, of the 10 studies reporting 
health-related behaviours, five had a follow-up period of a 
year or more and three a period of 6 months. It is therefore 
unlikely that the studies as a whole were too short to detect 
changes in behaviour or reflected only immediate unsus-
tained changes.
A further limitation is that many of the interventions 
consisted of provision of personalised risk information 
alongside a range of additional information, either 
written or delivered in person or in groups. Separating 
the effect of the risk information from those additional 
elements of the interventions was therefore not possible. 
However, we chose not to exclude these studies from this 
review because it is unlikely that personalised risk infor-
mation would be incorporated into routine practice in 
isolation and, if anything, including them would overesti-
mate the effect of the personalised risk information. It is 
also possible that the findings do not reflect the potential 
impact of interventions incorporating personalised infor-
mation about cancer risk on the general population as 
a whole: half of the included studies focused on female 
cancers and so only recruited women and all were subject 
to recruitment bias with the participants who agreed to 
take part potentially more interested in their cancer risk 
or more healthy, resulting in a bias in either direction.
In addition to these specific limitations of our review, 
the findings also suggest a number of areas for future 
research. In particular, the absence of studies assessing 
the impact on diet, physical activity and alcohol consump-
tion and only one study reporting smoking cessation 
demonstrate the need for trials assessing change in 
these behaviours, preferably measured objectively, 
including measures of other theory-based determinants 
of behaviour change (eg, self-efficacy). Only with such 
data will we be able to assess whether such individual-
ised approaches have a place alongside population-wide 
prevention strategies.
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